Australia's largest stock trading and investment forum Australia's #1 stock forum

RHT

3.28%

5.9¢ resonance health limited

Ann: R&D Update - Molecular Medicine ASO Project, page-3

First 3 Last

Share
Profile

Follow
MapleSyrup

43 Posts.

16

17/05/21

12:08

Post #: 53219865
Share

Originally posted by bobadah: ↑

Quote - "In a preclinical cell model of HBV infection, AS3 demonstrated statistically significant viral suppression compared to a control ASO."
Resonance Health ASO R&D Project leader, Dr. Sherif Boulos, commented: “Our positive data validates our ASO treatment strategy for chronic HBV, consolidates our intellectual property position, and supports continued investigation of AS3 in a preclinical animal model of disease. Shortly, we will commence a dosage study to test its effectiveness in a humanisedliver mouse strain. If successful, we aim to investigate if AS3 is effective in an HBV infection model using the same strain. Successful elimination of HBV will require a multi-drug approach, and because AS3 targets a human protein essential for viral growth, it is ideally suited to this purpose. In combination with other treatments, AS3 would also help to mitigate the emergence of drug resistant mutants, which is an important clinical consideration.”

This looks like a promising trial getting underway.

Expand

I am in for a bit at .19c - looks interesting. Followed you into IMU and was not disappointed so will give this one a shot

RHT Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

IMA

Issues emerging as Australian companies tackle critical minerals challenge

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

There are more pages in this discussion • 10 more messages in this thread...

First 3 Last

Add RHT (ASX) to my watchlist

(20min delay)
Last 5.9¢		Change -0.002(3.28%)		Mkt cap ! $26.36M

Open	High	Low	Value	Volume
5.9¢	5.9¢	5.6¢	$13K	224.9K

Buyers (Bids)

No.	Vol.	Price($)
4	70523	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.9¢	18035	1

View Market Depth

No.	Vol.	Price($)
4	70523	0.056
1	60241	0.055
1	91000	0.054
2	241999	0.050
1	10306	0.049

Price($)	Vol.	No.
0.059	18035	1
0.065	55000	2
0.067	29344	1
0.068	522	1
0.069	45000	1

Last trade - 13.58pm 11/10/2024 (20 minute delay)

RHT (ASX) Chart

Ann: R&D Update - Molecular Medicine ASO Project, page-3

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Cauldron Energy reports "excellent" uranium assays in latest drill run

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Issues emerging as Australian companies tackle critical minerals challenge

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: R&D Update - Molecular Medicine ASO Project, page-3

Top Stories

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Cauldron Energy reports "excellent" uranium assays in latest drill run

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Issues emerging as Australian companies tackle critical minerals challenge

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News